148 related articles for article (PubMed ID: 22067439)
1. The anti-inflammatory effect of paraoxonase 1 against oxidized lipids depends on its association with high density lipoproteins.
Loued S; Isabelle M; Berrougui H; Khalil A
Life Sci; 2012 Jan; 90(1-2):82-8. PubMed ID: 22067439
[TBL] [Abstract][Full Text] [Related]
2. Extra-virgin olive oil consumption reduces the age-related decrease in HDL and paraoxonase 1 anti-inflammatory activities.
Loued S; Berrougui H; Componova P; Ikhlef S; Helal O; Khalil A
Br J Nutr; 2013 Oct; 110(7):1272-84. PubMed ID: 23510814
[TBL] [Abstract][Full Text] [Related]
3. Effect of dietary lipids on paraoxonase-1 activity and gene expression.
Ferretti G; Bacchetti T
Nutr Metab Cardiovasc Dis; 2012 Feb; 22(2):88-94. PubMed ID: 22118836
[TBL] [Abstract][Full Text] [Related]
4. Effect of 3,4-dihydroxyphenylalanine on Cu(2+)-induced inactivation of HDL-associated paraoxonasel and oxidation of HDL; inactivation of paraoxonasel activity independent of HDL lipid oxidation.
Nguyen SD; Sok DE
Free Radic Res; 2004 Sep; 38(9):969-76. PubMed ID: 15621715
[TBL] [Abstract][Full Text] [Related]
5. HDL-paraoxonase and membrane lipid peroxidation: a comparison between healthy and obese subjects.
Ferretti G; Bacchetti T; Masciangelo S; Bicchiega V
Obesity (Silver Spring); 2010 Jun; 18(6):1079-84. PubMed ID: 19834469
[TBL] [Abstract][Full Text] [Related]
6. Effect of PON1 polymorphism on HDL antioxidant potential is blunted with aging.
Cherki M; Berrougui H; Isabelle M; Cloutier M; Koumbadinga GA; Khalil A
Exp Gerontol; 2007 Aug; 42(8):815-24. PubMed ID: 17532162
[TBL] [Abstract][Full Text] [Related]
7. The effect of HDL-bound and free PON1 on copper-induced LDL oxidation.
Bayrak A; Bayrak T; Bodur E; Kılınç K; Demirpençe E
Chem Biol Interact; 2016 Sep; 257():141-6. PubMed ID: 27510818
[TBL] [Abstract][Full Text] [Related]
8. Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes.
Rosenblat M; Karry R; Aviram M
Atherosclerosis; 2006 Jul; 187(1):74-81. PubMed ID: 16229851
[TBL] [Abstract][Full Text] [Related]
9. Oxidative inactivation of paraoxonase1, an antioxidant protein and its effect on antioxidant action.
Nguyen SD; Sok DE
Free Radic Res; 2003 Dec; 37(12):1319-30. PubMed ID: 14753756
[TBL] [Abstract][Full Text] [Related]
10. Macrophage paraoxonase 1 (PON1) binding sites.
Efrat M; Aviram M
Biochem Biophys Res Commun; 2008 Nov; 376(1):105-10. PubMed ID: 18762170
[TBL] [Abstract][Full Text] [Related]
11. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.
Aviram M; Rosenblat M; Bisgaier CL; Newton RS; Primo-Parmo SL; La Du BN
J Clin Invest; 1998 Apr; 101(8):1581-90. PubMed ID: 9541487
[TBL] [Abstract][Full Text] [Related]
12. Systemic inflammation, intestine, and paraoxonase-1.
Vakili L; Navab KD; Shabihkhani M; Pourtabatabaei N; Vazirian S; Barseghian Z; Seyedali S; Hough G
Adv Exp Med Biol; 2014; 824():83-8. PubMed ID: 25038995
[TBL] [Abstract][Full Text] [Related]
13. ApoE induces serum paraoxonase PON1 activity and stability similar to ApoA-I.
Gaidukov L; Viji RI; Yacobson S; Rosenblat M; Aviram M; Tawfik DS
Biochemistry; 2010 Jan; 49(3):532-8. PubMed ID: 20025294
[TBL] [Abstract][Full Text] [Related]
14. Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks.
Sumegová K; Blazícek P; Waczulíková I; Zitnanová I; Duracková Z
Acta Biochim Pol; 2006; 53(4):783-7. PubMed ID: 17106515
[TBL] [Abstract][Full Text] [Related]
15. Age-related decrease in high-density lipoproteins antioxidant activity is due to an alteration in the PON1's free sulfhydryl groups.
Jaouad L; de Guise C; Berrougui H; Cloutier M; Isabelle M; Fulop T; Payette H; Khalil A
Atherosclerosis; 2006 Mar; 185(1):191-200. PubMed ID: 16026789
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of paraoxonase 1 of high-density lipoprotein in type 2 diabetic patients with nephropathy.
Li C; Gu Q
Nephrology (Carlton); 2009 Aug; 14(5):514-20. PubMed ID: 19207863
[TBL] [Abstract][Full Text] [Related]
17. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
[TBL] [Abstract][Full Text] [Related]
18. HDL oxidability and its protective effect against LDL oxidation in Type 2 diabetic patients.
Sanguinetti SM; Brites FD; Fasulo V; Verona J; Elbert A; Wikinski RL; Schreier LE
Diabetes Nutr Metab; 2001 Feb; 14(1):27-36. PubMed ID: 11345163
[TBL] [Abstract][Full Text] [Related]
19. The PON1 M55L gene polymorphism is associated with reduced HDL-associated PAF-AH activity.
Kakafika AI; Xenofontos S; Tsimihodimos V; Tambaki AP; Lourida ES; Kalaitzidis R; Cariolou MA; Elisaf M; Tselepis AD
J Lipid Res; 2003 Oct; 44(10):1919-26. PubMed ID: 12867538
[TBL] [Abstract][Full Text] [Related]
20. Lack of protection against oxidative modification of LDL by avian HDL.
Mackness B; Durrington PN; Mackness MI
Biochem Biophys Res Commun; 1998 Jun; 247(2):443-6. PubMed ID: 9642147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
